NKGen Biotech's market value is the price at which a share of NKGen Biotech trades on a public exchange. It measures the collective expectations of NKGen Biotech Common investors about its performance. NKGen Biotech is selling at 0.06 as of the 26th of January 2026; that is No Change since the beginning of the trading day. The stock's open price was 0.06. With this module, you can estimate the performance of a buy and hold strategy of NKGen Biotech Common and determine expected loss or profit from investing in NKGen Biotech over a given investment horizon. Check out NKGen Biotech Correlation, NKGen Biotech Volatility and NKGen Biotech Alpha and Beta module to complement your research on NKGen Biotech.
Please note, there is a significant difference between NKGen Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if NKGen Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NKGen Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
NKGen Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to NKGen Biotech's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of NKGen Biotech.
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure NKGen Biotech's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess NKGen Biotech Common upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for NKGen Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as NKGen Biotech's standard deviation. In reality, there are many statistical measures that can use NKGen Biotech historical prices to predict the future NKGen Biotech's volatility.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as NKGen Biotech. Your research has to be compared to or analyzed against NKGen Biotech's peers to derive any actionable benefits. When done correctly, NKGen Biotech's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in NKGen Biotech Common.
NKGen Biotech January 26, 2026 Technical Indicators
NKGen Biotech is out of control given 3 months investment horizon. NKGen Biotech Common has Sharpe Ratio of 0.22, which conveys that the firm had a 0.22 % return per unit of risk over the last 3 months. We were able to analyze and collect data for nineteen different technical indicators, which can help you to evaluate if expected returns of 2.23% are justified by taking the suggested risk. Use NKGen Biotech Common risk adjusted performance of 0.1854, and Mean Deviation of 6.88 to evaluate company specific risk that cannot be diversified away. NKGen Biotech holds a performance score of 17 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of -0.32, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning NKGen Biotech are expected to decrease at a much lower rate. During the bear market, NKGen Biotech is likely to outperform the market. Use NKGen Biotech Common coefficient of variation, total risk alpha, as well as the relationship between the Total Risk Alpha and rate of daily change , to analyze future returns on NKGen Biotech Common.
Auto-correlation
0.65
Good predictability
NKGen Biotech Common has good predictability. Overlapping area represents the amount of predictability between NKGen Biotech time series from 28th of October 2025 to 12th of December 2025 and 12th of December 2025 to 26th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of NKGen Biotech Common price movement. The serial correlation of 0.65 indicates that roughly 65.0% of current NKGen Biotech price fluctuation can be explain by its past prices.
Correlation Coefficient
0.65
Spearman Rank Test
0.97
Residual Average
0.0
Price Variance
0.0
Pair Trading with NKGen Biotech
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if NKGen Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NKGen Biotech will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to NKGen Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace NKGen Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back NKGen Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling NKGen Biotech Common to buy it.
The correlation of NKGen Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as NKGen Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if NKGen Biotech Common moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for NKGen Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Other Information on Investing in NKGen Pink Sheet
NKGen Biotech financial ratios help investors to determine whether NKGen Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in NKGen with respect to the benefits of owning NKGen Biotech security.